MiMedx appoints Ricci S. Whitlow as COO effective January 3, 2023

MIMEDX GROUP, INC.

Whitlow most recently President, Clinical Supply Services at Catalent; 30+ years MedTech experience.
Compensation: base salary $540k, target bonus 50% of base, sign-on $50k, RSU grant of 300% of base salary.
Will lead manufacturing, supply chain, procurement, quality, and regulatory functions.
Severance benefits: 1.25x base+bonus for no-cause termination, 1.5x upon change in control.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ricci S. Whitlow

Executive Vice President and Chief Operating Officer

MDXG · MIMEDX GROUP, INC.

Effective: 2023-01-03
Filed: January 3, 2023, 6:59 PM ET

On January 3, 2023, MiMedx Group, Inc. (the “Company”) appointed Ricci S. Whitlow as its Executive Vice President and Chief Operating Officer, and issued a press release in connection therewith, which is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Ricci S. Whitlow was appointed as Executive Vice President and Chief Operating Officer at MIMEDX GROUP, INC..

Action: appointed
Role: Executive Vice President and Chief Operating Officer

Exact text from the filing

On January 3, 2023, MiMedx Group, Inc. (the “Company”) appointed Ricci S. Whitlow as its Executive Vice President and Chief Operating Officer, and issued a press release in connection therewith, which is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein.

View on SEC.gov

MIMEDX GROUP, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-000889

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.